X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2196) 2196
oncology (1638) 1638
high-dose methotrexate (1587) 1587
female (1235) 1235
male (1155) 1155
index medicus (1075) 1075
chemotherapy (1011) 1011
adult (898) 898
middle aged (805) 805
hematology (731) 731
antineoplastic combined chemotherapy protocols - therapeutic use (729) 729
methotrexate (713) 713
adolescent (593) 593
treatment outcome (582) 582
cancer (574) 574
child (549) 549
aged (546) 546
high-dose chemotherapy (514) 514
methotrexate - administration & dosage (488) 488
prognosis (428) 428
therapy (376) 376
combined modality therapy (358) 358
child, preschool (348) 348
non-hodgkins-lymphoma (344) 344
pharmacology & pharmacy (340) 340
care and treatment (325) 325
primary cns lymphoma (319) 319
retrospective studies (311) 311
acute lymphoblastic-leukemia (306) 306
transplantation (303) 303
disease-free survival (298) 298
children (294) 294
osteosarcoma (283) 283
survival rate (278) 278
methotrexate - adverse effects (272) 272
antineoplastic combined chemotherapy protocols - adverse effects (270) 270
radiotherapy (253) 253
survival (247) 247
pediatrics (240) 240
antineoplastic combined chemotherapy protocols - administration & dosage (237) 237
methotrexate - therapeutic use (235) 235
phase-ii (227) 227
lymphomas (219) 219
toxicity (218) 218
research (217) 217
clinical neurology (216) 216
antineoplastic agents - therapeutic use (212) 212
cyclophosphamide - administration & dosage (212) 212
survival analysis (212) 212
risk factors (209) 209
stem-cell transplantation (209) 209
follow-up studies (207) 207
osteosarcoma - drug therapy (207) 207
medicine & public health (203) 203
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (202) 202
cisplatin (197) 197
pharmacokinetics (195) 195
bone-marrow-transplantation (192) 192
infant (187) 187
cyclophosphamide (186) 186
doxorubicin (184) 184
neoadjuvant chemotherapy (184) 184
animals (183) 183
adjuvant chemotherapy (182) 182
health aspects (181) 181
bone neoplasms - drug therapy (180) 180
rituximab (180) 180
bone-marrow transplantation (176) 176
doxorubicin - administration & dosage (173) 173
dose-response relationship, drug (172) 172
immunology (170) 170
leukemia (169) 169
young adult (169) 169
lymphoma (165) 165
cisplatin - administration & dosage (164) 164
central-nervous-system (161) 161
remission induction (161) 161
central nervous system neoplasms - drug therapy (159) 159
hematopoietic stem cell transplantation (156) 156
analysis (149) 149
whole-brain radiotherapy (146) 146
neoplasm staging (145) 145
cytarabine - administration & dosage (144) 144
aged, 80 and over (143) 143
drug administration schedule (142) 142
transplantation, autologous (142) 142
antimetabolites, antineoplastic - administration & dosage (141) 141
antimetabolites, antineoplastic - therapeutic use (141) 141
recurrence (139) 139
fluorouracil - administration & dosage (138) 138
fluorouracil (136) 136
trial (136) 136
vincristine - administration & dosage (134) 134
acute lymphocytic-leukemia (133) 133
antimetabolites, antineoplastic - adverse effects (133) 133
drug therapy (133) 133
high-dose therapy (132) 132
stem cells (131) 131
surgery (131) 131
central nervous system neoplasms - therapy (130) 130
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2801) 2801
French (46) 46
German (37) 37
Japanese (20) 20
Spanish (9) 9
Russian (7) 7
Polish (5) 5
Korean (3) 3
Slovenian (2) 2
Turkish (2) 2
Hungarian (1) 1
Italian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Hematological Oncology, ISSN 0278-0232, 12/2017, Volume 35, Issue 4, pp. 504 - 509
Journal Article
Oncologist, ISSN 1083-7159, 12/2016, Volume 21, Issue 12, pp. 1471 - 1482
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 9, pp. 949 - 959
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Blood, ISSN 0006-4971, 02/2013, Volume 121, Issue 6, pp. 898 - 904
Journal Article